WoodTrust Financial’s Biodesix BDSX Stock Holding History

WoodTrust Financial’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-503	Closed	-$53K	–	144
2021 Q4	$53K	Buy	+503	New	+$65.7K	0.01%	139

Other funds holding BDSX

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

WoodTrust Financial's BDSX Position: Q1 2022 in Review

WoodTrust Financial sold out of Biodesix (BDSX) in Q1 2022, closing a stake of 503 shares — an estimated $53K sold.

WoodTrust Financial first reported a position in BDSX in Q4 2021 and held it in 1 quarter. The position peaked at $53K in Q4 2021. 46 funds tracked by Wall St. Rank hold BDSX as of Q1 2022.

WoodTrust Financial reported no remaining Biodesix position as of Q1 2022 after selling out during the quarter.
WoodTrust Financial sold 503 Biodesix shares in Q1 2022, an estimated $53K.
WoodTrust Financial first reported a position in Biodesix in Q4 2021 and held it in 1 quarter.
WoodTrust Financial's Biodesix position peaked at $53K in Q4 2021.
46 funds tracked by Wall St. Rank held Biodesix as of Q1 2022.

Based on WoodTrust Financial's 13F filing for Q1 2022, filed 25 Apr 2022.